These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 22809646
1. Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy. Jain V, Swarnakar NK, Mishra PR, Verma A, Kaul A, Mishra AK, Jain NK. Biomaterials; 2012 Oct; 33(29):7206-20. PubMed ID: 22809646 [Abstract] [Full Text] [Related]
2. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J, Chuan X, Zhang H, Dai W, Wang X, Wang X, Zhang Q. Int J Pharm; 2014 Aug 25; 471(1-2):525-35. PubMed ID: 24858391 [Abstract] [Full Text] [Related]
3. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies. Freag MS, Elnaggar YS, Abdelmonsif DA, Abdallah OY. Int J Nanomedicine; 2016 Aug 25; 11():4799-4818. PubMed ID: 27703348 [Abstract] [Full Text] [Related]
4. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor. Chen L, Chen B, Deng L, Gao B, Zhang Y, Wu C, Yu N, Zhou Q, Yao J, Chen J. Int J Pharm; 2017 Dec 20; 534(1-2):308-315. PubMed ID: 28986321 [Abstract] [Full Text] [Related]
5. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy. Oh KS, Song JY, Cho SH, Lee BS, Kim SY, Kim K, Jeon H, Kwon IC, Yuk SH. J Control Release; 2010 Dec 20; 148(3):344-50. PubMed ID: 20797418 [Abstract] [Full Text] [Related]
6. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability. Zeng N, Hu Q, Liu Z, Gao X, Hu R, Song Q, Gu G, Xia H, Yao L, Pang Z, Jiang X, Chen J, Fang L. Int J Pharm; 2012 Mar 15; 424(1-2):58-66. PubMed ID: 22240390 [Abstract] [Full Text] [Related]
7. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity. Wang F, Shen Y, Xu X, Lv L, Li Y, Liu J, Li M, Guo A, Guo S, Jin F. Int J Pharm; 2013 Nov 01; 456(1):101-12. PubMed ID: 23968782 [Abstract] [Full Text] [Related]
8. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. J Control Release; 2009 Jan 05; 133(1):11-7. PubMed ID: 18950666 [Abstract] [Full Text] [Related]
9. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite. Yuk SH, Oh KS, Cho SH, Kim SY, Oh S, Lee JH, Kim K, Kwon IC. Mol Pharm; 2012 Feb 06; 9(2):230-6. PubMed ID: 22149139 [Abstract] [Full Text] [Related]
10. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Jiang X, Xin H, Sha X, Gu J, Jiang Y, Law K, Chen Y, Chen L, Wang X, Fang X. Int J Pharm; 2011 Nov 28; 420(2):385-94. PubMed ID: 21920419 [Abstract] [Full Text] [Related]
11. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel. Xu H, Fan M, Elhissi AM, Zhang Z, Wan KW, Ahmed W, Phoenix DA, Sun X. Nanomedicine (Lond); 2015 Nov 28; 10(8):1247-62. PubMed ID: 25955123 [Abstract] [Full Text] [Related]
12. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug. Battogtokh G, Kang JH, Ko YT. Eur J Pharm Biopharm; 2015 Oct 28; 96():96-105. PubMed ID: 26212785 [Abstract] [Full Text] [Related]
13. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice. Dalela M, Shrivastav TG, Kharbanda S, Singh H. ACS Appl Mater Interfaces; 2015 Dec 09; 7(48):26530-48. PubMed ID: 26528585 [Abstract] [Full Text] [Related]
14. Preparation and biological evaluation of paclitaxel loaded biodegradable PCL/PEG nanoparticles for the treatment of human neuroendocrine pancreatic tumor in mice. Dubey N, Shukla J, Hazari PP, Varshney R, Ganeshpurkar A, Mishra AK, Trivedi P, Bandopadhaya GP. Hell J Nucl Med; 2012 Dec 09; 15(1):9-15. PubMed ID: 22413106 [Abstract] [Full Text] [Related]
15. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Yu DH, Lu Q, Xie J, Fang C, Chen HZ. Biomaterials; 2010 Mar 09; 31(8):2278-92. PubMed ID: 20053444 [Abstract] [Full Text] [Related]
16. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X. Int J Pharm; 2010 Dec 15; 402(1-2):238-47. PubMed ID: 20934500 [Abstract] [Full Text] [Related]
17. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, Ji W, Wu B, Han J, Zhang H, Wang H, Chang J, Niu R. Eur J Pharm Biopharm; 2012 Jun 15; 81(2):248-56. PubMed ID: 22446630 [Abstract] [Full Text] [Related]
18. Self-assembled polymeric nanoparticle of PEGylated chitosan-ceramide conjugate for systemic delivery of paclitaxel. Battogtokh G, Ko YT. J Drug Target; 2014 Nov 15; 22(9):813-21. PubMed ID: 24964055 [Abstract] [Full Text] [Related]
20. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo. Chuan X, Song Q, Lin J, Chen X, Zhang H, Dai W, He B, Wang X, Zhang Q. Mol Pharm; 2014 Oct 06; 11(10):3656-70. PubMed ID: 25208098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]